Summary

The global endocrine testing market size reached US$ 11.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.

Endocrine testing refers to the medical procedures conducted to measure the hormonal levels in the body and the diagnosis of hormone-related disorders. The testing aids in detecting an imbalance in the concentrations of hormones that may lead to the development of certain chronic conditions. These disorders are usually tested by fine-needle aspiration (FNA), ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI), positron emission test (PET), radioactive iodine scan (RAI) and venous sampling. The test results thus obtained can assist in determining the progression of the disorder and monitoring the effects of the treatment being provided to the patient.

The increasing prevalence of endocrine-related disorders, such as adrenal insufficiency, Cushing’s disease, gigantism, hypothyroidism and hyperthyroidism, represents one of the key factors driving the growth of the market. Furthermore, the increasing health consciousness and awareness regarding the benefits of timely testing is providing a boost to the market growth. Periodic testing minimizes the risks of developing complications or aggravation of the disorder, especially in elderly patients. In line with this, the rising geriatric population is acting as another major growth-inducing factor. Moreover, due to the onset of the coronavirus (COVID-19) pandemic, endocrine testing is being widely used to detect hyperglycemia in infected patients. Additionally, the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market. Healthcare centers, laboratories and diagnostic centers are also using technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to provide highly precise and accurate results. Other factors, including improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global endocrine testing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on test type, technology, and end use.
Breakup by Test Type:
• Thyroid Test
• Insulin Test
• Human Chorionic Gonadotropin Test
• Prolactin Test
• Luteinizing Hormone Test
• Progesterone Test
• Others

Breakup by Technology:
• Immunoassay
• Tandem Mass Spectroscopy
• Sensor Technology
• LC-MS
• Others

Breakup by End Use:
• Hospitals
• Ambulatory Care Centers
• Clinical Laboratories
• Others

Breakup by Region:
• North America
o United States
o Canada
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche AG (Roche Holding AG), Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens Aktiengesellschaft) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:
• How has the global endocrine testing market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global endocrine testing market?
• What are the key regional markets?
• What is the breakup of the market based on the test type?
• What is the breakup of the market based on the technology?
• What is the breakup of the market based on the end use?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global endocrine testing market and who are the key players?
• What is the degree of competition in the industry?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Endocrine Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Test Type
6.1 Thyroid Test
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Insulin Test
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Human Chorionic Gonadotropin Test
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Prolactin Test
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Luteinizing Hormone Test
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Progesterone Test
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Technology
7.1 Immunoassay
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Tandem Mass Spectroscopy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Sensor Technology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 LC-MS
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End Use
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Care Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinical Laboratories
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Agilent Technologies Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bio-Rad Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 BioMerieux SA
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 DiaSorin S.p.A.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG (Roche Holding AG)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 Laboratory Corporation of America Holdings
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Quest Diagnostics Incorporated
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Siemens Healthineers AG (Siemens Aktiengesellschaft)
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Thermo Fisher Scientific Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Endocrine Testing Market: Major Drivers and Challenges
Figure 2: Global: Endocrine Testing Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Endocrine Testing Market: Breakup by Test Type (in %), 2023
Figure 4: Global: Endocrine Testing Market: Breakup by Technology (in %), 2023
Figure 5: Global: Endocrine Testing Market: Breakup by End Use (in %), 2023
Figure 6: Global: Endocrine Testing Market: Breakup by Region (in %), 2023
Figure 7: Global: Endocrine Testing Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: Global: Endocrine Testing (Thyroid Test) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Endocrine Testing (Thyroid Test) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Endocrine Testing (Insulin Test) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Endocrine Testing (Insulin Test) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Endocrine Testing (Prolactin Test) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Endocrine Testing (Prolactin Test) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Endocrine Testing (Luteinizing Hormone Test) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Endocrine Testing (Luteinizing Hormone Test) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Endocrine Testing (Progesterone Test) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Endocrine Testing (Progesterone Test) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Endocrine Testing (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Endocrine Testing (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Endocrine Testing (Immunoassay) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Endocrine Testing (Immunoassay) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Endocrine Testing (Sensor Technology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Endocrine Testing (Sensor Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Endocrine Testing (LC-MS) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Endocrine Testing (LC-MS) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Endocrine Testing (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Endocrine Testing (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Endocrine Testing (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Endocrine Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Endocrine Testing (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Endocrine Testing (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Endocrine Testing (Clinical Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Endocrine Testing (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Endocrine Testing (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Endocrine Testing (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: North America: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: North America: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: United States: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: United States: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Canada: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Canada: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Asia Pacific: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Asia Pacific: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: China: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: China: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Japan: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Japan: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: India: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: India: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: South Korea: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: South Korea: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Australia: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Australia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Indonesia: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Indonesia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Europe: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Europe: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Germany: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Germany: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: France: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: France: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: United Kingdom: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: United Kingdom: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Italy: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Italy: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Spain: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Spain: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Russia: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Russia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Latin America: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Latin America: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Brazil: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Brazil: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Mexico: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Mexico: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Others: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Middle East and Africa: Endocrine Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Middle East and Africa: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Global: Endocrine Testing Industry: SWOT Analysis
Figure 89: Global: Endocrine Testing Industry: Value Chain Analysis
Figure 90: Global: Endocrine Testing Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Endocrine Testing Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Endocrine Testing Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
Table 3: Global: Endocrine Testing Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Endocrine Testing Market Forecast: Breakup by End Use (in Million US$), 2024-2032
Table 5: Global: Endocrine Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Endocrine Testing Market Structure
Table 7: Global: Endocrine Testing Market: Key Players